ATLANTA–(BUSINESS WIRE)–Aug. January 2022–
Axion BioSystems, a leading life science tools company, announced the appointment of David Ferrick as Chief Scientific Officer. dr Ferrick comes to Axion with over 20 years of experience commercializing life science products in new and emerging markets.
This press release is multimedia. View the full press release here: https://www.businesswire.com/news/home/20220125005325/en/
David Ferrick, Chief Scientific Officer, Axion BioSystems. (Photo: Business Wire)
“David’s extensive knowledge of immunology and cancer, combined with his experience leading innovative new tools, make him an ideal choice to advance the Maestro platform,” said Tom O’Brien, CEO of Axion BioSystems. “As we continue to expand our position in the immuno-oncology market, his expertise will be invaluable and I look forward to where David will take us.”
dr Ferrick comes to Axion BioSystems from Agilent Technologies, where he led new market development and strategy for the Cell Analysis Division. Prior to that, he was CSO at Seahorse Bioscience and held senior positions in several biotech companies. He has led commercialization efforts for many emerging life science products, including diagnostic and drug screening programs from target identification to preclinical testing.
dr Ferrick began his career as a professor-turned-entrepreneur at the University of California and is currently a leader in the life sciences industry focused on drug discovery and diagnostics in the fields of immunology and cancer. He is the author of over 150 peer-reviewed publications, inventor of 20 patents, and has contributed to numerous high-profile peer-reviewed articles and interviews. dr Ferrick received his Ph.D. in Microbiology and Immunology from Georgetown University in Washington DC
“Axion’s innovative bioelectronic solutions have transformed the way scientists approach neurological disease research, and I see the same potential for emerging areas such as immuno-oncology and immune-based medicines, which inevitably have become very cell-centric. I look forward to continuing to build on their momentum and growth as I take on this new role,” said Dr. Ferric.
About Axion BioSystems
Axion BioSystems is a leading life science tools company focused on the development and commercialization of label-free, bioelectronic assays for studying living cell function in vitro for drug discovery and disease modeling. The Axion BioSystems team is dedicated to advancing bioelectronic assay technology that enables understanding of biological complexity outside of the body. Axion BioSystems is headquartered in Atlanta, Georgia, USA and also has an office in Shanghai, China. Axion employs more than 60 people at its current locations. www.axionbiosystems.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220125005325/en/
CONTACT: Mike Clements
KEYWORD: UNITED STATES NORTH AMERICA GEORGIA
INDUSTRY KEY WORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH OTHER HEALTH
SOURCE: Axion BioSystems
Copyright Business Wire 2022.
PUB: 01/26/2022 00:00 / DISC: 01/26/2022 00:02
Copyright Business Wire 2022.